First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

528 Reviews

Credit Rating - DR. ABRAR LIMITED

ANALYSIS
Credit Risk Update: ACCOUNTS DUE FLAG: DR. ABRAR LIMITED, Suite 1, Parkway 5, Emerson Business Centre, 300 Princess Road, Manchester, M14 7HR. The legal status is a Private Limited Company and the current status at the registry of companies is Dissolved. The last filed accounts are dated 28 February 2018. The company was incorporated on 14 February 2011.

The accounts next due date is 30 November 2019. There are no mortgages.

The above was based on public record information as at 31 January 2025 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 07528232
Date Incorporated: 14 February 2011
Date Latest Accounts: 28 February 2018
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 07528232
Annual Return: 14 April 2016
Registered Office: Suite 1, Parkway 5, Emerson Business Centre, 300 Princess Road, Manchester, M14 7HR
SIC Code and Operations: 86210
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

DR. ABRAR LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 10 February 2025 Copyright © 2025 First Report Ltd


Recent Searches

Reg No. Reg Name Status
14089303 DR. ADAM AESTHETICS LTD Active
11949494 DR. ADAMS LABORATORIES LTD Active
15115843 DR. ADAMS PHARMACEUTICALS LTD Active
13035691 DR. ADAM'S TUTORING LIMITED Active
13415285 DR. ADJABENG MEDICALS LTD Active

In using this service you agree to the Terms and Conditions

© 2025 First Report Ltd